Mikael Dolsten - Dec 17, 2021 Form 4 Insider Report for PFIZER INC (PFE)

Role
President R&D
Signature
Susan E. Grant, by power of atty., for Mikael Dolsten
Stock symbol
PFE
Transactions as of
Dec 17, 2021
Transactions value $
$647,686
Form type
4
Date filed
12/21/2021, 05:31 PM
Previous filing
Nov 15, 2021
Next filing
Feb 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $2.15M +71.2K +25.38% $30.17 352K Dec 17, 2021 Direct F1
holding PFE Common Stock 1.8K Dec 17, 2021 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities -$1.5M -25.2K -35.42% $59.48 46K Dec 17, 2021 Common Stock 25.2K Direct F2, F3, F4
transaction PFE Stock Appreciation Rights Options Exercise $0 -152K -100% $0.00* 0 Dec 17, 2021 Common Stock 152K $30.17 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in Pfizer common stock price (20 trading day average ending on the exercise date (Election Price of $53.791)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant.
F2 Each unit represents one phantom share of common stock.
F3 The reporting person diversified shares held in the Pfizer Inc. Deferred Compensation Plan (Plan) pursuant to the Plan's diversification provision into an alternate investment option(s) under the Plan.
F4 The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.